Advanced search
Publication Cover
Journal of Chemotherapy Volume 33, 2021 - Issue 1
Submit an article Journal homepage
307
Views
2
CrossRef citations to date
0
Altmetric
Brief Communication

Weight-based vancomycin loading strategy may not improve achievement of optimal vancomycin concentration in patients with preserved renal function

Si-Ho Kim1 Division of Infectious Diseases, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of KoreaORCID Iconhttps://orcid.org/0000-0001-7763-8940View further author information
ORCID Icon,
Cheol-In Kang2 Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1741-4459View further author information
ORCID Icon,
Soo-Hyun Lee2 Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaView further author information
,
Joon-Sik Choi3 Division of Pediatric Infectious Diseases and Immunodeficiency, Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-5587-2960View further author information
ORCID Icon,
Kyungmin Huh2 Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-5140-3964View further author information
ORCID Icon,
Sun Young Cho2 Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaView further author information
,
Doo Ryeon Chung2 Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaView further author information
,
Hyo Jung Park4 Department of Pharmaceutical Services, Samsung Medical Center, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-3875-0224View further author information
ORCID Icon,
Soo-Youn Lee5 Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaView further author information
,
Yae-Jean Kim3 Division of Pediatric Infectious Diseases and Immunodeficiency, Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaView further author information
&
Kyong Ran Peck2 Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaView further author information
 show all
Pages 56-61 | Received 13 Jan 2020, Accepted 09 Apr 2020, Published online: 23 Apr 2020

References

  • Moellering RC Jr. Vancomycin: a 50-year reassessment. Clin Infect Dis. 2006;42(Supplement_1):S3–S4.
  • Alvarez R, Lopez Cortes LE, Molina J, Cisneros JM, Pachon J. Optimizing the clinical use of vancomycin. Antimicrob Agents Chemother. 2016;60(5):2601–9.
  • Colin PJ, Allegaert K, Thomson AH, Touw DJ, Dolton M, de Hoog M, Roberts JA, Adane ED, Yamamoto M, Santos-Buelga D, et al. Vancomycin pharmacokinetics throughout life: results from a pooled population analysis and evaluation of current dosing recommendations. Clin Pharmacokinet. 2019;58(6):767–80.
  • Golenia BS, Levine AR, Moawad IM, Yeh DD, Arpino PA. Evaluation of a vancomycin dosing nomogram based on the modification of diet in renal disease equation in intensive care unit patients. J Crit Care. 2013;28(5):710–6.
  • Giuliano C, Haase KK, Hall R. Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections. Exp Rev Anti-Infect Ther. 2010;8(1):95–106.
  • Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M, Dalovisio JR, Levine DP. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009;49(3):325–7.
  • Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet. 2004;43(13):925–42.
  • Han HK, An H, Shin KH, Shin D, Lee SH, Kim JH, et al. Trough concentration over 12.1 mg/L is a major risk factor of vancomycin-related nephrotoxicity in patients with therapeutic drug monitoring. Ther Drug Monit. 2014;36(5):606–11.
  • Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration–time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis. 2009;49(4):507–14.
  • Truong J, Levkovich BJ, Padiglione AA. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels. Intern Med J. 2012;42(1):23–9.
  • Rosini JM, Laughner J, Levine BJ, Papas MA, Reinhardt JF, Jasani NB. A randomized trial of loading vancomycin in the emergency department. Ann Pharmacother. 2015;49(1):6–13.
  • Alvarez O, Plaza-Plaza JC, Ramirez M, Peralta A, Amador CA, Amador R. Pharmacokinetic assessment of vancomycin loading dose in critically ill patients. Antimicrob Agents Chemother. 2017;61(8). doi:10.1128/AAC.00280-17
  • Šíma M, Hartinger J, Cikánková T, Slanař O. Importance of vancomycin loading doses in intermittent infusion regimens. J Infect Chemother. 2018;24(4):247–50.
  • Mei H, Wang J, Che H, Wang R, Cai Y. The clinical efficacy and safety of vancomycin loading dose: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(43):e17639.
  • Park SJ, Yang JH, Park HJ, In YW, Lee YM, Cho YH, Chung CR, Park C-M, Jeon K, Suh GY. Trough concentrations of vancomycin in patients undergoing extracorporeal membrane oxygenation. PloS One. 2015;10(11):e0141016.
  • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
  • Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–12.
  • Bakke V, Sporsem H, Von der Lippe E, Nordøy I, Lao Y, Nyrerød HC, Sandvik L, Hårvig KR, Bugge JF, Helset E. Vancomycin levels are frequently subtherapeutic in critically ill patients: a prospective observational study. Acta Anaesthesiol Scand. 2017;61(6):627–35.
  • Baptista JP, Sousa E, Martins PJ, Pimentel JM. Augmented renal clearance in septic patients and implications for vancomycin optimisation. Int J Antimicrob Agents. 2012;39(5):420–3.
  • Mizuno T, Mizokami F, Fukami K, Ito K, Shibasaki M, Nagamatsu T. The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia. Clin Interv Aging. 2013;8:1323–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.